|
Survivor group
(n = 43)
|
Non-survivor group
(n = 59)
|
P
|
WBC (x103/mL) |
14.9 ± 6.1 |
15.2 ± 7.9 |
0.850 |
Neutrophil (x103/mL) |
9.5 (4.3-14.0) |
9.6 (6.9-16.5) |
0.169 |
Lymphocyte
(x103/mL) |
3.5 (1.9-5.8) |
2.6 (1.5-3.2) |
0.008 |
Monocyte (x103/mL) |
0.6 (0.4-0.9) |
0.5 (0.3-0.8) |
0.261 |
Hemoglobin (g/dL) |
13.6 ± 2.5 |
13.3 ± 2.5 |
0.551 |
Platelet (x103/mL) |
263 (210-313) |
243 (180-317) |
0.169 |
MCV (fL) |
91.4 ± 9.1 |
90.0 ± 6.8 |
0.364 |
RDW (%) |
12.8 ± 1.5 |
14.9 ± 10.5 |
0.195 |
NLR |
2.9 (1.0-5.7) |
4.5 (3.3-5.9) |
0.012 |
PLR |
79 (37-170) |
92 (61-176) |
0.146 |
Glucose, mg/dl |
250 (160-318) |
304 (175-407) |
0.272 |
Creatinine, mg/dl |
1.2 ± 0.4 |
1.4 ± 0.4 |
0.144 |
Na (mEq/L) |
138.6 ± 5.4 |
139.5 ± 4.7 |
0.372 |
K (mEq/L) |
4.4 ± 0.6 |
4.7 ± 0.9 |
0.107 |
Ca (mEq/L) |
10.4 ± 11.0 |
8.5 ± 0.8 |
0.197 |
AST, IU |
68 (33-163) |
102 (42-370) |
0.067 |
ALT, IU |
63 (31-127) |
72 (33-267) |
0.102 |
CRP, |
1.9 (0.8-4.5) |
6.4 (1.9-11.8) |
<0.001 |
Albumin, g/dl |
3.8 ± 0.4 |
3.4 ± 0.6 |
<0.001 |
CAR |
0.5 (0.2-1.3) |
1.6 (0.5-3.3) |
<0.001 |
PH |
7.2 ± 0.2 |
7.1 ± 0.2 |
0.056 |
Lactate |
4.4 (2.5-7.0) |
7 (3.8-11.2) |
0.002 |